Study guide

3.4 Hemolysis, Clotting & Specimen Integrity Factors

ASCP Phlebotomy Technician PBT

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Patient Identification, Preparation & Equipment

1.1 Patient Identification & Requisition Verification 1.2 Phlebotomy Equipment, Needles & Antiseptics 1.3 Order of Draw, Additives & Tube Inversions 1.4 Site Selection, Vein Palpation & Skin Preparation

2 Chapter 2: Venipuncture & Capillary Skin Puncture Techniques

2.1 Standard Evacuated Tube Venipuncture Step-by-Step 2.2 Winged Infusion Sets & Difficult Vein Access 2.3 Capillary / Skin Puncture Protocols & Order of Draw 2.4 Pediatric & Geriatric Special Populations

3 Chapter 3: Preanalytical Complications & Special Blood Collections

3.1 Preanalytical Complications & Failure to Draw 3.2 Blood Culture Collection Protocols & Contamination Prevention 3.3 Special Blood Collections (Timed, Fasting, GTT, TDM) 3.4 Hemolysis, Clotting & Specimen Integrity Factors

4 Chapter 4: Specimen Transport, Processing & Storage

4.1 Specimen Labeling, Barcoding & Chain of Custody 4.2 Specimen Transport, Temperature & Light Sensitivity Requirements 4.3 Centrifugation, Aliquoting & Specimen Storage 4.4 Specimen Acceptability & Rejection Criteria

5 Chapter 5: Laboratory Operations, Safety & Regulatory Compliance

5.1 Infection Control, Standard Precautions & Bloodborne Pathogens 5.2 Laboratory Safety, Chemical Hygiene & Waste Disposal 5.3 Quality Assurance, Quality Control & Preanalytical Risk Management 5.4 Legal, Ethical & Regulatory Considerations (HIPAA, CLIA, OSHA) 5.5 Interprofessional Communication & Patient Interaction

6 Chapter 6: Circulatory System Anatomy & Physiology

6.1 Vascular Anatomy & Upper Extremity Vein Selection 6.2 Composition of Blood & Cellular Elements 6.3 Hemostasis, Coagulation Cascade & Anticoagulant Actions

7 Chapter 7: Point-of-Care Testing (POCT) & CLIA-Waived Procedures

7.1 Point-of-Care Testing (POCT) & CLIA-Waived Principles 7.2 POCT Quality Control, Calibration & Maintenance 7.3 Common POCT Procedures (Glucose, Coagulation, Hemoglobin/Hematocrit)

8 Chapter 8: Non-Blood Specimen Collection & Special Handling

8.1 Urine Specimen Collection Protocols & Types 8.2 Stool, Sputum & Throat Swab Collections 8.3 Cerebrospinal Fluid, Synovial & Other Body Fluids Handling

3.4 Hemolysis, Clotting & Specimen Integrity Factors

Key Takeaways Explain This Topic AI

Hemolysis is the destruction of red blood cells releasing intracellular contents, causing false elevations in potassium, LDH, AST, magnesium, and iron.

Technical causes of hemolysis include using small needles (25G), vigorous tube shaking, drawing from a hematoma, forceful syringe pulling, wet alcohol sites, and improper centrifugation.

Lipemic serum appears milky white due to high triglycerides, while icteric serum appears dark yellow/amber due to elevated bilirubin; both interfere with optical laboratory assays.

Underfilling sodium citrate (light blue) tubes disrupts the required 9:1 blood-to-anticoagulant ratio, producing falsely prolonged coagulation times (PT/INR, aPTT).

Centrifuging serum tubes before complete clotting (30-60 minutes) causes fibrin formation that clogs laboratory analyzers, while re-centrifuging gel barrier tubes causes cellular rupture.

Last updated: July 2026

Hemolysis, Clotting & Specimen Integrity Factors

The diagnostic validity of every laboratory test relies directly upon the physical and biochemical integrity of the blood specimen submitted for analysis. Preanalytical variables account for more than 70% of all diagnostic testing errors encountered in clinical laboratories. When blood specimens suffer physical destruction, accidental clot formation, or contamination, the resulting laboratory data become severely distorted. Recognizing the causes of specimen compromise—such as hemolysis, lipemia, icterus, and micro-clotting—and understanding how these artifacts skew numerical test values is a primary competency assessed on the ASCP Phlebotomy Technician (PBT) examination.

Hemolysis: Definition, Causes, and Mechanisms

Hemolysis is defined as the destruction or lysis of red blood cell (RBC) membranes, resulting in the release of intracellular hemoglobin and cytoplasm into the surrounding liquid portion (plasma or serum) of the blood specimen. Upon centrifugation, hemolyzed serum or plasma exhibits a characteristic light pink to deep red discoloration.

  • Intact Red Blood Cells (Centrifuged) : Clear Yellow Serum / Plasma (Normal)
  • Ruptured Red Blood Cells (Hemolysis) : Pink to Deep Red Serum / Plasma (Compromised)
  • Technical Causes of In Vitro Hemolysis

In vitro hemolysis (hemolysis caused by technical error during collection or processing) is the single most frequent reason for laboratory specimen rejection.

Needle Gauge Selection : Using a needle lumen that is too small ( 25-gauge or smaller ) subjects red blood cells to extreme shearing forces as they are pulled into the collection container.

Traumatic Venipuncture & Probing : Excessive lateral probing or drawing blood from a site with an active or developing hematoma introduces damaged, hemolyzed cells into the sample.

Vigorous Tube Inversion : Shaking collection tubes violently instead of performing gentle, rhythmic 180-degree inversions mechanically ruptures fragile RBC membranes.

Forceful Syringe Transfer : Pulling a syringe plunger back with excessive force or forcing blood through a syringe needle into an evacuated tube using manual pressure causes high-velocity shear stress.

Wet Alcohol Site : Inserting the needle before the 70% isopropyl alcohol prep has completely air-dried allows chemical alcohol to enter the vein lumen, causing chemical lysis of red blood cells.

Improper Centrifugation : Centrifuging specimens at excessive relative centrifugal force (RCF/speed), centrifuging unclotted serum tubes, or re-centrifuging gel tubes damages red cells and forces intracellular contents into the supernatant.

Diagnostic Impact of Hemolysis on Laboratory Results

Red blood cells contain extremely high internal concentrations of specific electrolytes, enzymes, and minerals compared to extracellular plasma. When RBCs lyse, these intracellular components flood into the serum, producing severe diagnostic artifacts.

Analytes Falsely ELEVATED by Hemolysis Analytes Falsely DECREASED by Hemolysis

Potassium ( K + K^+ K + ) (Intracellular concentration is 20 times higher than plasma) Red Blood Cell (RBC) Count

  • Lactate Dehydrogenase (LDH) (Massive intracellular enzyme concentration) Hematocrit (Hct)
  • Aspartate Aminotransferase (AST) (Hepatic/cardiac/RBC enzyme) Troponin I (Certain assay interference)
  • Magnesium ( M g 2 + Mg^{2+} M g 2 + ) & Iron Bilirubin (In severe spectrographic masking)
  • Phosphorus & Total Protein
  • Clinical Danger of Hemolytic Artifacts

The most dangerous clinical consequence of hemolysis is the false elevation of serum potassium ( K + K^+ K + ) . A false potassium reading of 6.2 mEq/L (pseudohyperkalemia) caused by hemolysis can lead a physician to treat a healthy patient for a life-threatening cardiac arrhythmia, administering glucose and insulin unnecessarily. Consequently, laboratories enforce a strict policy: grossly hemolyzed specimens for potassium testing must be rejected and re-drawn immediately .

Non-Clear Serum Alterations: Lipemia & Icterus

In addition to hemolysis, two other physical conditions alter serum/plasma appearance and disrupt laboratory instruments: lipemia and icterus .

  • Condition Physical Appearance Primary Underlying Cause
  • Lipemia Milky, cloudy, or turbid white Elevated triglycerides/chylomicrons
  • Icterus Dark yellow to amber/olive-brown Elevated serum bilirubin (jaundice)
  • Hemolysis Light pink to deep cherry-red Free hemoglobin from RBC lysis
  • Lipemia

Mechanism : Lipemia occurs when high concentrations of large lipoprotein particles (chylomicrons and triglycerides) accumulate in the blood.

Causes : Drawing blood from a patient who is non-fasting (having recently consumed a high-fat meal) or a patient suffering from severe hypertriglyceridemia or lipid metabolism disorders.

Laboratory Impact : Lipemic turbidity scatters light in automated spectrophotometers and analyzers, causing inaccurate, falsely elevated readings for hemoglobin, total protein, and total bilirubin, while causing false dilutions in indirect electrolyte measurements.

Icterus

Mechanism : Icterus is caused by an abnormal accumulation of bilirubin (a yellow breakdown product of heme metabolism) exceeding 2.5 to 3.0 mg/dL in the blood.

Causes : Liver disease, hepatitis, cirrhosis, biliary tract obstruction, or severe hemolytic anemias.

Laboratory Impact : Deep amber/brown icteric serum absorbs light at specific wavelengths (450-500 nm), interfering with colorimetric reactions and enzymatic chemical assays.

Specimen Clotting & Anticoagulant Ratio Failures

Anticoagulated collection tubes (such as Lavender EDTA, Light Blue Sodium Citrate, and Green Heparin) are designed to preserve blood in a fluid state or prevent micro-clot formation. Unexpected clotting in an anticoagulated tube renders the specimen completely useless for testing.

Causes of Specimen Clotting

Inadequate or Delayed Tube Inversion : Anticoagulant tubes must be inverted gently 5 to 10 times immediately upon collection . Delaying inversion allows the coagulation cascade to initiate, forming fibrin micro-clots inside the tube.

Improper Order of Draw : Drawing an additive tube before an anticoagulant tube or transferring blood out of order can contaminate tubes with tissue thromboplastin, triggering rapid micro-clotting.

Slow, Difficult Venipuncture : Prolonged draws allow tissue fluid (thromboplastin) from the puncture site to mix with blood in the needle hub before entering the tube, overwhelming the anticoagulant.

Blood-to-Anticoagulant Ratio Errors (Underfilling Tubes)

Evacuated tubes are manufactured with a precise volume of liquid or spray-dried anticoagulant calibrated for a full draw.

Sodium Citrate (Light Blue Top) : Requires a strict 9:1 blood-to-anticoagulant ratio (9 parts blood to 1 part 3.2% liquid sodium citrate).

Impact of Underfilling : If a light blue tube is underfilled (e.g., filled half full), the relative excess of liquid sodium citrate dilutes the patient's plasma and binds excessive calcium reagents added during testing. This results in falsely prolonged Prothrombin Time (PT/INR) and Activated Partial Thromboplastin Time (aPTT) values.

EDTA (Lavender / Pink Top) : Underfilling an EDTA tube results in excessive EDTA concentration relative to blood volume. Excess EDTA causes red blood cells to shrink (crenation) , falsely decreasing the hematocrit (Hct) and mean corpuscular volume (MCV) while altering cell morphology on blood smears.

Centrifugation Standards & Serum Separation

Proper specimen processing requires strict adherence to centrifugation parameters to maintain specimen stability.

Complete Clotting Duration : Serum tubes without clot activators require 30 to 60 minutes to clot completely at room temperature before centrifugation. Gel barrier tubes with clot activators require 30 minutes.

Premature Centrifugation Hazard : Centrifuging a serum tube before clotting is complete results in ongoing fibrin formation in the separated serum. The forming fibrin strands clog automated analyzer sampling probes, causing instrument breakdown and erroneous test results.

Gel Barrier Integrity : Thixotropic gel barrier tubes (SST / PST) move to the serum/cell interface during centrifugation, forming a physical barrier. Tubes must never be re-centrifuged once this gel barrier has formed, as re-centrifuging ruptures cells trapped beneath the gel and forces intracellular potassium and enzymes into the supernatant serum.